Global Nature of Terrorism Drives Biosurveillance

WASHINGTON, Oct. 27, 2011 — The glob­al nature of ter­ror­ism and the grow­ing poten­tial of nations and indi­vid­u­als to acquire weapons of mass destruc­tion dri­ve the Defense Department’s effort to counter these threats, the assis­tant sec­re­tary of defense for nuclear, chem­i­cal and bio­log­i­cal defense pro­grams said today.

 -
Under high mag­ni­fi­ca­tion, this 2002 scan­ning elec­tron micro­graph shows spores from a strain of anthrax.
Pho­to cour­tesy of The Cen­ters for Dis­ease Con­trol and Pre­ven­tion
Click to enlarge

Andrew C. Weber said DOD pro­grams tar­get nuclear deter­rence, seek out ear­ly warn­ing for infec­tious dis­eases, and bol­ster the abil­i­ty of U.S. part­ners around the world to pre­vent, pre­pare for and respond to events involv­ing WMD. “Our nation­al secu­ri­ty strat­e­gy makes pre­vent­ing and prepar­ing for the pos­si­bil­i­ty that ter­ror­ist groups would acquire weapons of mass destruc­tion, whether it be bio­log­i­cal weapons or nuclear weapons, our first pri­or­i­ty,” Weber said dur­ing an inter­view here with Amer­i­can Forces Press Ser­vice and the Pen­ta­gon Channel. 

The 2001 ter­ror­ist attacks on New York, Penn­syl­va­nia and the Pen­ta­gon drove home the glob­al nature of ter­ror­ism, the assis­tant sec­re­tary said. 

Lat­er that year, he said, a series of anthrax attacks in the Unit­ed States caused defense offi­cials “to focus more atten­tion on the pos­si­bil­i­ty that ter­ror­ist groups would acquire bio­log­i­cal or nuclear weapons and use them against cities here or around the world.” 

Since 9/11, he added, the Defense Depart­ment has broad­ly improved its response to ter­ror­ist nuclear, chem­i­cal and espe­cial­ly bio­log­i­cal threats, which can be acces­si­ble to small groups, ter­ror cells and even individuals. 

“This is why it’s so dif­fi­cult to dis­rupt and to learn about these types of attacks while they’re being planned,” Weber said, “so we need to be very prepared.” 

Amer­i­can forces are now vac­ci­nat­ed against anthrax and small­pox, he said, and the depart­ment has stock­piled antibi­otics against poten­tial bio­log­i­cal attacks. 

“In a sense, we have tak­en parts of the bio­log­i­cal threat off the table,” Weber said, “by improv­ing our capa­bil­i­ty for med­ical coun­ter­mea­sures and ear­ly warn­ing and surveillance.” 

To keep ter­ror­ist groups from get­ting access to mate­ri­als need­ed to con­struct bio­log­i­cal weapons, he said, DOD has helped strength­en biose­cu­ri­ty at lab­o­ra­to­ries in the Unit­ed States. 

“We also have launched a pro­gram work­ing with part­ners around the world to make sure pub­lic health and vet­eri­nary lab­o­ra­to­ries that have dan­ger­ous pathogen strains that cause dis­eases like anthrax and ebo­la are bet­ter secured,” the assis­tant sec­re­tary said. 

Some kinds of bio­log­i­cal attacks by ter­ror­ists, he said, could look at first just like nat­ur­al dis­ease outbreaks. 

“We might not know about it until peo­ple or even ani­mals show up sick or start dying,” he said, “so the best thing you can do [is] to have a glob­al ear­ly warn­ing sys­tem for bio­log­i­cal attacks, whether they are delib­er­ate or natural.” 

The Defense Depart­ment has sev­er­al pro­grams that involve glob­al bio­sur­veil­lance, Weber said, includ­ing the Glob­al Emerg­ing Infec­tions Sur­veil­lance and Response Sys­tem, or GEIS, a divi­sion of the Armed Forces Health Sur­veil­lance Center. 

For 50 years, he said, DOD has had a net­work of bio­med­ical lab­o­ra­to­ries in coun­tries around the world that are part of this system. 

The lab­o­ra­to­ries allow DOD sci­en­tists to devel­op drugs for rare dis­eases that are not endem­ic in the Unit­ed States but that may be in coun­tries where U.S. forces are deployed, Weber said. 

“They also give us a good plat­form,” he added, “for enhanc­ing region­al part­ner capac­i­ty to detect and mon­i­tor and respond to infec­tious dis­ease outbreaks.” 

Humans today inhab­it an inter­con­nect­ed world,” Weber said, so a dis­ease out­break any­where on the plan­et is a poten­tial glob­al threat. 

“That’s why we need to work with our part­ners to have a glob­al sys­tem for ear­ly warn­ing,” he said. 

Ear­ly warn­ing sys­tems for dis­eases, based on good lab­o­ra­to­ry diag­nos­tics and infor­ma­tion sys­tems for track­ing sick peo­ple, he added, are “essen­tial because the most-impor­tant aspect of pre­vent­ing mass casu­al­ties in a bio­log­i­cal attack is time.” 

The Defense Depart­ment has a robust pro­gram to devel­op med­ical coun­ter­mea­sures and rapid diag­nos­tics for a range of spe­cif­ic bio­log­i­cal threats, Weber said, that ter­ror­ist groups and coun­tries like North Korea are pursuing. 

Weber said DOD works close­ly with the Cen­ters for Dis­ease Con­trol and Pre­ven­tion in Atlanta, and with the World Health Orga­ni­za­tion, which has glob­al respon­si­bil­i­ties under the Unit­ed Nations for improv­ing the world’s capa­bil­i­ty to respond to infec­tious dis­ease out­breaks and work­ing with health author­i­ties world­wide in the event of an out­break or attack. 

“The Depart­ment of Defense has a liai­son offi­cer assigned to WHO Head­quar­ters,” he said, “and recent­ly the U.S. gov­ern­ment signed an agree­ment with WHO [to fund] some efforts to enhance capa­bil­i­ties around the world to mon­i­tor infec­tious diseases.” 

In coun­ter­ing future bio­log­i­cal threats, the assis­tant sec­re­tary said, research and devel­op­ment plays an impor­tant role. 

“With the rev­o­lu­tion in biotech­nol­o­gy … the range of threats is poten­tial­ly infi­nite,” Weber said, “so we need a rapid response capa­bil­i­ty after expo­sure, once we iden­ti­fy what is caus­ing the dis­ease, to devel­op a drug quick­ly, with­in weeks or days, rather than the years … it takes now.” 

The Defense Depart­ment has its own bio­log­i­cal research lab­o­ra­to­ries, he said, that work on devel­op­ing med­ical prod­ucts and it also works with indus­tri­al and aca­d­e­m­ic part­ners around the world. 

“Agen­cies like DARPA [Defense Advanced Research Projects Agency] and the Defense Threat Reduc­tion Agency have been very active in fund­ing biode­fense research,” Weber said. 

The focus, he said, is on find­ing rapid ways to respond to a bio­log­i­cal attack from an unknown agent, quick­ly char­ac­ter­ize it and devel­op a countermeasure. 

“Rather than hav­ing a drug or a vac­cine for every poten­tial [threat],” Weber said, “we need a capa­bil­i­ty to respond quick­ly, to be able to char­ac­ter­ize what is caus­ing ill­ness, and then to devel­op as quick­ly as pos­si­ble a med­ical coun­ter­mea­sure to save lives.” 

Source:
U.S. Depart­ment of Defense
Office of the Assis­tant Sec­re­tary of Defense (Pub­lic Affairs) 

More news and arti­cles can be found on Face­book and Twitter.

Fol­low GlobalDefence.net on Face­book and/or on Twit­ter

Team GlobDef

Team GlobDef

Seit 2001 ist GlobalDefence.net im Internet unterwegs, um mit eigenen Analysen, interessanten Kooperationen und umfassenden Informationen für einen spannenden Überblick der Weltlage zu sorgen. GlobalDefenc.net war dabei die erste deutschsprachige Internetseite, die mit dem Schwerpunkt Sicherheitspolitik außerhalb von Hochschulen oder Instituten aufgetreten ist.

Alle Beiträge ansehen von Team GlobDef →